Naproxen
Naproxen is a generic nonsteroidal anti-inflammatory drug (NSAID) that helps reduce pain, inflammation, and fever. Manufactured by Aurobindo Pharma Limited, it's available as oral tablets in strengths of 250 mg, 375 mg, and 500 mg for prescription use. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Naproxen is a generic nonsteroidal anti-inflammatory drug (NSAID) that helps reduce pain, inflammation, and fever. Manufactured by Aurobindo Pharma Limited, it's available as oral tablets in strengths of 250 mg, 375 mg, and 500 mg for prescription use. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Naproxen",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Naproxen — ANDA 074190 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074190"
}
]
|
| identifier | ANDA074190 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"health-care",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Naproxen |
